These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 22370517)

  • 1. Japanese encephalitis vaccine: need of the hour in endemic states of India.
    Verma R
    Hum Vaccin Immunother; 2012 Apr; 8(4):491-3. PubMed ID: 22370517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Fischer M; Lindsey N; Staples JE; Hills S;
    MMWR Recomm Rep; 2010 Mar; 59(RR-1):1-27. PubMed ID: 20224546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological situation of Japanese encephalitis in Nepal.
    Bista MB; Shrestha JM
    JNMA J Nepal Med Assoc; 2005; 44(158):51-6. PubMed ID: 16554872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergic reactions to Japanese encephalitis vaccine.
    Plesner AM
    Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of SA 14-14-2 vaccination on the occurrence of Japanese encephalitis in India.
    Muniaraj M; Rajamannar V
    Hum Vaccin Immunother; 2019; 15(4):834-840. PubMed ID: 30681400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):661-3. PubMed ID: 21617632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO
    Amicizia D; Zangrillo F; Lai PL; Iovine M; Panatto D
    J Prev Med Hyg; 2018 Mar; 59(1):E99-E107. PubMed ID: 29938245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.
    Appaiahgari MB; Vrati S
    Expert Rev Vaccines; 2010 Dec; 9(12):1371-84. PubMed ID: 21105774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical development of IMOJEV ®--a recombinant Japanese encephalitis chimeric vaccine (JE-CV).
    Appaiahgari MB; Vrati S
    Expert Opin Biol Ther; 2012 Sep; 12(9):1251-63. PubMed ID: 22775524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japanese Encephalitis Among Three U.S. Travelers Returning from Asia, 2003-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jul; 58(27):737-40. PubMed ID: 19609246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices.
    Hills SL; Walter EB; Atmar RL; Fischer M;
    MMWR Recomm Rep; 2019 Jul; 68(2):1-33. PubMed ID: 31518342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Japanese encephalitis and Japanese encephalitis virus in mainland China.
    Zheng Y; Li M; Wang H; Liang G
    Rev Med Virol; 2012 Sep; 22(5):301-22. PubMed ID: 22407526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of Japanese encephalitis in India: a reality.
    Kabilan L
    Indian J Pediatr; 2004 Aug; 71(8):707-12. PubMed ID: 15345871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Japanese encephalitis in South Korea, 2007-2010.
    Lee DW; Choe YJ; Kim JH; Song KM; Cho H; Bae GR; Lee JK
    Int J Infect Dis; 2012 Jun; 16(6):e448-52. PubMed ID: 22497964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies.
    Ginsburg AS; Meghani A; Halstead SB; Yaich M
    Hum Vaccin Immunother; 2017 Oct; 13(10):2222-2231. PubMed ID: 28841362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current burden of Japanese encephalitis and the estimated impacts of vaccination: Combining estimates of the spatial distribution and transmission intensity of a zoonotic pathogen.
    Moore SM
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009385. PubMed ID: 34644296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area.
    Turtle L; Tatullo F; Bali T; Ravi V; Soni M; Chan S; Chib S; Venkataswamy MM; Fadnis P; Yaïch M; Fernandez S; Klenerman P; Satchidanandam V; Solomon T
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005263. PubMed ID: 28135273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Japanese encephalitis SA 14-14-2 live attenuated vaccine among Indian children: Retrospective 1:4 matched case-control study.
    Tandale BV; Khan SA; Kushwaha KP; Rahman H; Gore MM;
    J Infect Public Health; 2018; 11(5):713-719. PubMed ID: 29703709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Travel-acquired Japanese encephalitis and vaccination considerations.
    Pavli A; Maltezou HC
    J Infect Dev Ctries; 2015 Sep; 9(9):917-24. PubMed ID: 26409731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk assessment for Japanese encephalitis vaccination.
    Turtle L; Driver C
    Hum Vaccin Immunother; 2018 Jan; 14(1):213-217. PubMed ID: 29244615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.